-+ 0.00%
-+ 0.00%
-+ 0.00%

Corvus Pharma Q3 EPS $(0.22), Inline

Benzinga·11/05/2026 21:05:54
Listen to the news
Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.22) per share which met the analyst consensus estimate. This is a 83.33 percent decrease over losses of $(0.12) per share from the same period last year.